Scientists increasingly see cancer as a genetic disease defined not so much by where it starts — colon, liver, brain, breast — but by genetic aberrations that are its Achilles' heel.
This pattern of tumor-initiation has subsequently been described in various solid tumors including brain, breast, pancreatic, prostate, and others [55]-[59] [55]-[59]
Ariad also has plans to study the drug in patients with brain, breast, endometrial and prostate cancers.
Usp9x has emerged as a potential therapeutic target in some hematologic malignancies and a broad range of solid tumors including brain, breast, and prostate.
However, most studies on nanoparticle-induced autophagy focus on brain, breast, and cervical cancers; limited reports are available on gastrointestinal (GI) cancers.
EGFRvIII is the most common deletion variant of the epidermal growth factor receptor and is found in cancers of the brain, breast, ovary, and lung.
Cowden syndrome is characterized by multiple hamartomas in various tissues, including the skin, brain, breast, thyroid, mucous membrane, and gastrointestinal tract, and is reported to increase the risk of malignant disease.
The three nanovector formulations where evaluated for safety and ability to promote gene silencing in three types of cancer cells C6/GFP+, MCF7/GFP+, and TC2/GFP+, mimicking human cancers of the brain, breast, and prostate, respectively.
In order to obtain a typical radioactivity concentration within organs with less location mismatch between PET and the co-registered MRI images (brain, breast, heart wall, heart contents, kidney, liver, lung, muscle, bones, spleen and thyroid), individual ROIs were drawn on co-registered MRI images.
The following input data were used: gender; age; population group (U.S. 2000 2005); exposure year; organs like brain, breast (females), colon, gallbladder, liver, lungs, ovaries (females), kidneys, pancreas, red bone marrow, stomach, thyroid, urinary bladder, uterus (females); exposure rate (acute); dose distribution type (fixed value); organ-specific absorbed doses [10].
CD90, another most important surface marker of CSCs, has been found in brain, breast, lung, liver, pancreatic, and esophageal cancer types (Woo et al., 2015; Wang et al., 2015; Khan and Mukhtar, 2015; Sukowati et al., 2013; Zhu et al., 2014; Tang et al., 2013).
